Home > Insider Trading > Filing (0001104659-22-031172)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1173281	Neubase Therapeutics Inc.	NBSE	Pharmaceutical Preparations (2834)	465622433

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313876	I Eric Richman	C/O 350 Technology Drive, Fourth Floor New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-03-01	1,580	$1.58	42,660	No	4	P	Direct
Common Stock	Acquisiton	2022-03-03	1,300	$1.72	43,960	No	4	P	Direct
Common Stock	Acquisiton	2022-03-04	1,000	$1.62	44,960	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	27,747	Indirect	See footnote

Footnotes

The power of attorney under which this form was signed is on file with the Commission.
Shares are held in a trust for the benefit of the Reporting Person with the Reporting Person and the Reporting Person's spouse serving as co-trustees.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
These shares were purchased in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased in at each separate transaction.